Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Higher doses of cranial irradiation are linked to permanent hair loss.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some common medications can harm male fertility, but many effects can be reversed.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Some breast cancer chemotherapy can cause permanent hair loss.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Bimatoprost is safe and effective for improving eyebrow hair.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.